多支冠状动脉旁路移植术治疗川崎病相关冠状动脉病变
本研究回顾性分析了36年间92例川崎病相关冠状动脉病变患者共102次CABG手术,比较单支与多支搭桥的远期结果。多支搭桥使用动脉移植物长期安全有效,非LAD区域桡动脉10年通畅率显著优于大隐静脉(91% vs 46%,P = .013)。
要点
- 多支CABG使用动脉移植物治疗川崎病相关冠脉病变长期可行、安全有效
- 非LAD区域桡动脉10年通畅率显著优于大隐静脉(91% vs 46%,P = .013)
- 单支与多支CABG的30年生存率无显著差异(93% vs 91%,P = .71)
核心结论
- 使用动脉移植物的多支CABG对晚期川崎病相关冠状动脉病变患者长期可行、安全且治疗有效。
研究设计与样本
- 回顾性队列研究,纳入36年间92例患者共102次CABG手术,按单支(n = 53)或多支(n = 49)CABG分组。
- CABG时平均年龄14.9 ± 10.4岁;胸廓内动脉、桡动脉和胃网膜动脉分别用于100例(98%)、18例(15%)和4例(4%)。
主要发现
- 30年生存率单支CABG为93%、多支CABG为91%(P = .71)。
- 无院内死亡,长期随访共6例死亡,两组间无显著差异。
- 25年无心脏事件率单支CABG为45.2%、多支CABG为68.5%(P = .228),左前降支(LAD)区域再干预是最常见事件。
- 胸廓内动脉-LAD桥血管25年通畅率单支CABG为81%、多支CABG为85%。
- 非LAD区域桡动脉10年通畅率显著高于大隐静脉桥(91% vs 46%,P = .013)。
临床怎么用
- 对晚期川崎病相关冠状动脉病变患者,可考虑使用动脉移植物行多支CABG以实现长期再血管化。
- 非LAD区域优先选用桡动脉而非大隐静脉可能获得更优的远期通畅率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although coronary artery bypass grafting (CABG) is the preferred choice for advanced Kawasaki disease (KD)-associated coronary artery disease, graft design such as number of grafts or type of conduits has not been fully established. We reviewed a series of patients who underwent single or multiple CABG for coronary artery disease of KD sequelae to investigate the optimum revascularization strategy. METHODS: We enrolled a consecutive series of 102 CABG surgeries in 92 patients during the last 36 years. Mean patient age at CABG was 14.9 ± 10.4 years. Internal thoracic artery, radial artery, and gastroepiploic artery were used in 100 (98%), 18 (15%), and 4 (4%) cases, respectively. Patients were divided into 2 groups by single (n = 53) or multiple (n = 49) CABG. RESULTS: Actuarial survival was 93% in single CABG and 91% in multiple CABG at 30 years (P = .71). There was no in-hospital mortality, but 6 deaths occurred long term, with no significant difference between the groups. Freedom from cardiac events was 45.2% in single CABG and 68.5% in multiple CABG at 25 years (P = .228), and reintervention to the left anterior descending (LAD) artery territory was the most common event. Graft patency of the internal thoracic artery-LAD artery graft was 81% in single CABG and 85% in multiple CABG at 25 years. Patency of the radial artery in the non-LAD artery territories was significantly greater than that of the saphenous vein graft at 10 years (91% vs 46%, P = .013). CONCLUSIONS: Multiple CABG using arterial conduits is feasible, safe, and therapeutically effective long term for patients with advanced KD-associated coronary artery disease.
引用
- Tadokoro N, Fujita T, Fukushima S, et al. Multiple Coronary Artery Bypass Grafting for Kawasaki Disease-Associated Coronary Artery Disease. Ann Thorac Surg. 2019. PMID: 31039352. doi:10.1016/j.athoracsur.2019.03.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。